Schedule 13D ownership disclosure
CINCOR PHARMA INC
Security class unavailable · CUSIP: 17240Y109
Event date: 2022-01-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-006437
- Form type
- SC 13D
- Filer
- CinCor Pharma, Inc.
- CIK
- CIK 1868734
- Filed
- Jan 21, 2022
- Reporting period
- Jan 11, 2022
- Description
- Schedule 13D beneficial ownership